Full Year 2020 Astellas Pharma Inc Earnings Call Transcript
[Interpreted] Yasukawa speaking. Good morning. Thank you very much for participating in our financial presentation for FY 2019. As was explained, please regard to early documents while you listen to my presentation. I will mention the page number during my presentation.
Please turn to Page 2. This is a cautionary statement regarding forward-looking information as usual, so I'd like to skip.
Page 3. Before going into the contents of the results, let me explain our efforts against the spread of COVID-19. Stable supply of drugs, quality control, compliance with rules and regulations, safety management and information provision must be continued. To do so under the business continuity plan, those instructed by the company are continuing to carry out our essential business under strict measures to prevent infections. In principle, we are refraining from sales activities. In all regions globally, we continue to provide and gather necessary information in accordance with the rules of each medical institution.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
